Loading...
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
Taxane therapy is commonly used in the treatment of metastatic breast cancer. However, most patients will eventually become refractory to these agents. Ixabepilone is a newly approved chemotherapeutic agent for the treatment of metastatic breast cancer. Although it targets microtubules similarly to...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2721395/ https://ncbi.nlm.nih.gov/pubmed/19707381 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|